IonSense and WHALE Biolabs announced a strategic alliance to provide analytical services for chemists utilizing high-throughput experimentation (HTE) in their laboratories. The use of HTE has created a bottleneck in product confirmation by mass spectrometry and reduces the speed of discovering new chemistries and optimizing compound synthesis routes.
“The WHALE Biolabs alliance will provide chemists with immediate access to our new DART JumpShot technology with the capability to analyze over 1000 samples per hour, and at a time when capital expenditures might be put on hold” said IonSense CEO, Brian Musselman.